Despite the fact that the use of botanicals and nutraceuticals may offer an opportunity for health promotion, the support of the scientific community is not unequivocal. In this editorial opinion paper, we discuss different issues associated with meaningful data collection to support the role of botanicals and nutraceuticals in health promotion. These discussions have been framed to reach an economically feasible approach to data collection to provide a safe and efficacious product based on meaningful science.
Prasad, C., Cicero, A., Petrini, O. (2017). PLANNING MEANINGFUL CLINICAL TRIALS WITH BOTANICALS AND NUTRACEUTICALS: NEED FORA CROSS-TALK BETWEEN SCIENCE, BUSINESS AND THE REGULATORY DEMAND. CURRENT TOPICS IN NUTRACEUTICALS RESEARCH, 15(2), 49-56.
PLANNING MEANINGFUL CLINICAL TRIALS WITH BOTANICALS AND NUTRACEUTICALS: NEED FORA CROSS-TALK BETWEEN SCIENCE, BUSINESS AND THE REGULATORY DEMAND
Cicero, AFGSecondo
Writing – Original Draft Preparation
;
2017
Abstract
Despite the fact that the use of botanicals and nutraceuticals may offer an opportunity for health promotion, the support of the scientific community is not unequivocal. In this editorial opinion paper, we discuss different issues associated with meaningful data collection to support the role of botanicals and nutraceuticals in health promotion. These discussions have been framed to reach an economically feasible approach to data collection to provide a safe and efficacious product based on meaningful science.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
